FDA approves new drug for chronic lymphocytic leukemia
On April 11, the U.S. the Food and Drug Administration (FDA) approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia who…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.